Viewing Study NCT05277402


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-01-12 @ 1:09 PM
Study NCT ID: NCT05277402
Status: COMPLETED
Last Update Posted: 2024-02-26
First Post: 2022-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Sponsor: Adagene Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module